Journal article icon

Journal article

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.

Abstract:

Serogroup C meningococcal conjugate vaccines, first launched in the UK in 1999, have been used successfully in Australia, Canada and several other European countries. Combination conjugate vaccines, containing more than one meningococcal polysaccharide, have been developed to broaden protection against the disease. A tetravalent meningococcal A, C, Y and W-135 conjugate vaccine was licensed for use in 11-55 year old adolescents and adults in the US in January 2005, and subsequently also in 2-...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1136/adc.2006.111500

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Paediatrics, Biomedical Research Centre
Publisher:
BMJ Publishing Group Ltd Publisher's website
Journal:
Archives of disease in childhood Journal website
Volume:
92
Issue:
10
Pages:
909-915
Publication date:
2007-10-05
DOI:
EISSN:
1468-2044
ISSN:
0003-9888
URN:
uuid:8d3bef64-8aa5-4d9a-bdce-3ec264bb8a45
Source identifiers:
119193
Local pid:
pubs:119193

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP